Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN951036 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Carboxypeptidase N Subunit 1 (CPN1) (AA 209-240), (Middle Region) antibody
- Antibody type
- Polyclonal
- Description
- Affinity Chromatography on Protein A
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 209-240, Middle Region
- Vial size
- 0.4 mL
- Storage
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease.
Replication of previous genome-wide association studies of bone mineral density in premenopausal American women.
Regulation of chemerin bioactivity by plasma carboxypeptidase N, carboxypeptidase B (activated thrombin-activable fibrinolysis inhibitor), and platelets.
Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes.
Structure and function of human plasma carboxypeptidase N, the anaphylatoxin inactivator.
Speliotes EK, Butler JL, Palmer CD, Voight BF, GIANT Consortium., MIGen Consortium., NASH CRN., Hirschhorn JN
Hepatology (Baltimore, Md.) 2010 Sep;52(3):904-12
Hepatology (Baltimore, Md.) 2010 Sep;52(3):904-12
Replication of previous genome-wide association studies of bone mineral density in premenopausal American women.
Ichikawa S, Koller DL, Padgett LR, Lai D, Hui SL, Peacock M, Foroud T, Econs MJ
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2010 Aug;25(8):1821-9
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2010 Aug;25(8):1821-9
Regulation of chemerin bioactivity by plasma carboxypeptidase N, carboxypeptidase B (activated thrombin-activable fibrinolysis inhibitor), and platelets.
Du XY, Zabel BA, Myles T, Allen SJ, Handel TM, Lee PP, Butcher EC, Leung LL
The Journal of biological chemistry 2009 Jan 9;284(2):751-8
The Journal of biological chemistry 2009 Jan 9;284(2):751-8
Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes.
Yuan X, Waterworth D, Perry JR, Lim N, Song K, Chambers JC, Zhang W, Vollenweider P, Stirnadel H, Johnson T, Bergmann S, Beckmann ND, Li Y, Ferrucci L, Melzer D, Hernandez D, Singleton A, Scott J, Elliott P, Waeber G, Cardon L, Frayling TM, Kooner JS, Mooser V
American journal of human genetics 2008 Oct;83(4):520-8
American journal of human genetics 2008 Oct;83(4):520-8
Structure and function of human plasma carboxypeptidase N, the anaphylatoxin inactivator.
Skidgel RA, Erdös EG
International immunopharmacology 2007 Dec 20;7(14):1888-99
International immunopharmacology 2007 Dec 20;7(14):1888-99
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
